Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Musunuru

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 18, 2015
Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR CohortL Murray, S Ramasamy, J Lilley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 17, 2017
Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost-Utility AnalysisJ Helou, S Torres, H B Musunuru, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 10, 2022
Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?S Jaishankar, P M Pifer, R Bhargava, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective TrialsYasir Alayed, Melanie Davidson, Stanley Liu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 18, 2015
Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR CohortL Murray, S Ramasamy, J Lilley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 17, 2017
Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost-Utility AnalysisJ Helou, S Torres, H B Musunuru, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 10, 2022
Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?S Jaishankar, P M Pifer, R Bhargava, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective TrialsYasir Alayed, Melanie Davidson, Stanley Liu, et al.
Pageof 1